Showing results (131-140 of 479) with videos related to
Sort By:
Pageof 48
Chemical Research in Toxicology|December 22, 1998
Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolitesM Reist, P A Carrupt, E Francotte, et al.Journal of Medicinal Chemistry|January 5, 1996
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship modelsP Gaillard, P A Carrupt, B Testa, et al.Journal of Medicinal Chemistry|June 8, 2000
Predicting blood-brain barrier permeation from three-dimensional molecular structureP Crivori, G Cruciani, P A Carrupt, et al.Neuropharmacology|July 1, 1990
Behavioural and pharmacokinetic studies on nicotine, cytisine and lobelineC Reavill, B Walther, I P Stolerman, et al.The Biochemical Journal|February 1, 1993
pH-dependence of warfarin binding to alpha 1-acid glycoprotein (orosomucoid)S Urien, F Brée, B Testa, et al.Journal of Computer-Aided Molecular Design|April 1, 1994
Molecular lipophilicity potential, a tool in 3D QSAR: method and applicationsP Gaillard, P A Carrupt, B Testa, et al.The Journal of Pharmacy and Pharmacology|March 1, 1981
A theoretical conformational study of substituted O-anisamides as models of a class of dopamine antagonistsA Pannatier, L Anker, B Testa, et al.The Biochemical Journal|November 15, 1991
pH-dependency of basic ligand binding to alpha 1-acid glycoprotein (orosomucoid)S Urien, F Brée, B Testa, et al.Journal of Medicinal Chemistry|May 1, 1986
Molecular electrostatic potential of orthopramides: implications for their interaction with the D-2 dopamine receptorH van de Waterbeemd, P A Carrupt, B TestaItalian Journal of Neurological Sciences|December 1, 1990
Amyotrophic lateral sclerosis: thyroid and prolactin hormone changes in thyrotropin-releasing hormone therapyD Testa, P G Chiodini, F Girotti, et al.Pageof 48